---
title: "VGT Gains 0.47% Despite AI Stock Exclusions, SLDB Receives FDA Orphan Drug Nod"
canonical_url: https://www.stockexpertai.com/journal/2026-01-13/vgt-gains-047-despite-ai-stock-exclusions-sldb-receives-fda-orphan-drug-nod
last_updated: 2026-01-13T06:07:57.468Z
section: "AI Signals"
author: "Alex Sterling"
publisher: Stock Expert AI
tickers: VGT, SLDB
content_type: journal-article
---

# VGT Gains 0.47% Despite AI Stock Exclusions, SLDB Receives FDA Orphan Drug Nod

## The Take
- Monitor VGT's holdings for AI exposure and SLDB's clinical trial progress following its FDA designation; broader tech strength continues.

_AI signals point to sector-specific opportunities amidst broader market trends. Keep a close watch on fund composition and regulatory approvals._

Markets are signaling something important today. The tech-heavy Vanguard Information Technology ETF (VGT) is showing resilience, even as its AI exposure faces scrutiny. Meanwhile, a smaller biotech player is seeing a boost from regulatory news. Here's a closer look:

**VGT: Under the AI Hood**
The Vanguard Information Technology ETF (VGT) climbed +0.47% today, despite recent reports highlighting its exclusion of key AI companies due to categorization issues. This suggests that while AI is a driving force, the broader tech sector is still attracting investment. Investors should examine the specific holdings within VGT to understand its true exposure to the AI boom.

**SLDB: Orphan Drug Boost**
Solid Biosciences (SLDB) is in focus after securing FDA Orphan Drug designation for SGT-212 in Friedreich's Ataxia. While SLDB dipped -0.95%, such designations can significantly impact a company's long-term prospects, offering potential market exclusivity and development incentives. Keep an eye on SLDB as it progresses through clinical trials.

**QQQ: Steady Climb**
The Invesco QQQ Trust (QQQ) is up +0.08% today. This continues the trend of tech strength. However, the gains are modest, suggesting a need for caution. A Wall Street strategist is predicting Ethereum could hit $62,000 this year.

## Related Tickers
- [VGT](https://www.stockexpertai.com/stock/vgt)
- [SLDB](https://www.stockexpertai.com/stock/sldb)

## Frequently Asked Questions

### What is the Vanguard Information Technology ETF (VGT)?
The Vanguard Information Technology ETF (VGT) is an exchange-traded fund that tracks the performance of the U.S. information technology sector. It provides investors with exposure to companies involved in technology hardware, software, semiconductors, and related services. VGT's performance can be influenced by broader tech trends and specific company developments.

### Why is SLDB stock trending?
Solid Biosciences (SLDB) is in focus due to receiving FDA Orphan Drug designation for its treatment SGT-212 for Friedreich's Ataxia. This designation provides incentives for drug development, including potential market exclusivity. Investors are watching SLDB as it progresses through clinical trials to assess its long-term prospects.

---
_AI-generated under human editorial supervision. Educational research, not financial advice._